Options Data for US Stocks: End-of-Day and Historical Learn more

Aldeyra The icon

Aldeyra The (ALDX NASDAQ) stock market data APIs

$0.6487 -0.04(-6.2%)
as of November 13, 2026
Try our APIs with free plan!

Aldeyra The Financial Data Overview

Price chart is built with Anychart

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Prev. Close 0.6487
Open 0.6054
High 0.6533
Low 0.587
52 wk Range 0.527-5.93
Market Cap 38 858 K
Shares Outstanding 60 357 K
EPS -0.06
Beta 1.287

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Aldeyra The (top by weight)

Ticker
100-day Price Change
Weight
QQQS.US Invesco NASDAQ Future Gen 200 ETF
-6.73 (-15.17%)
0.26
IWC.US iShares Micro-Cap ETF
-25.45 (-12.81%)
0.01
PRFZ.US Invesco FTSE RAFI US 1500 Small-Mid ETF
-3.23 (-5.78%)
0.00
VHT.US Vanguard Health Care Index Fund ETF Shares
36.75 (11.81%)
0.00
VXF.US Vanguard Extended Market Index Fund ETF Shares
-16.77 (-6.8%)
0.00
DFAS.US DFA Investment Dimensions Group Inc.
-3.7 (-4.44%)
0.00
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
-9.71 (-2.55%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Aldeyra The data using free add-ons & libraries


Get Aldeyra The Fundamental Data

Aldeyra The logo

Aldeyra The Fundamental data includes:

  • Net Revenue:
  • EBITDA: -19 844 448
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Aldeyra The Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-11
  • EPS/Forecast: -0.11
GET THE PACKAGE

Get Aldeyra The End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Aldeyra The News

Get Aldeyra The fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.